The Novel Combination of Nitroxoline and PD-1 Blockade, Exerts a Potent Antitumor Effect in a Mouse Model of Prostate Cancer

Programmed cell death protein 1 (PD-1) blockade is a promising therapeutic strategy against prostate cancer. Nitroxoline has been found to have effective anticancer properties in several cancer types. We investigated the efficacy of a combination therapy involving nitroxoline and PD-1 blockade in a...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Naijin, Huang, Linglong, Li, Xiezhao, Watanabe, Masami, Li, Chaoming, Xu, Abai, Liu, Chunxiao, Li, Qiang, Araki, Motoo, Wada, Koichiro, Nasu, Yasutomo, Huang, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535792/
https://www.ncbi.nlm.nih.gov/pubmed/31182913
http://dx.doi.org/10.7150/ijbs.32259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535792/
https://www.ncbi.nlm.nih.gov/pubmed/31182913
http://dx.doi.org/10.7150/ijbs.32259

Ejemplares similares